Extract

This is a multi-center, randomized, placebo-controlled, flexible-dose, parallel-group study designed to evaluate the efficacy and safety of lurasidone (in combination with lithium or divalproex) for the maintenance treatment of bipolar I disorder in subjects with or without rapid cycling and /or psychotic features.

Inclusion criteria

• Bipolar I Disorder

Country

• Argentina
• Australia
• Bulgaria
• Chile
• Croatia
• Czech Republic
• France
• Hungary
• Japan
• Poland
• Russian Federation
• Serbia
• Slovakia
• United States

Links

• nct
• ictrp